Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2077316

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2077316

COVID-19 Detection Kits Market, By Product Type, By Specimen Type, By End User, By Geography

PUBLISHED:
PAGES: 250+ Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

COVID-19 Detection Kits Market is estimated to be valued at USD 4.74 Bn in 2026 and is expected to reach USD 5.67 Bn by 2033, growing at a compound annual growth rate (CAGR) of 2.6% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 4.74 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 2.60% 2033 Value Projection: USD 5.67 Bn

COVID-19 detection kits can identify the SARS-CoV-2 or coronavirus through two methods. The first method is the RT-PCR method in which the presence of the virus itself is detected and the second is an immunoassay test which detects antibodies produced in response to the infection. In order to prevent further spread of the virus, governments and regulatory authorities all over the world are focusing on conducting maximum number of COVID-19 detection tests which has led to a high demand for COVID-19 detection kits globally. For instance, on April 04, 2020, the Department of Health and Social Care, UK, reported that National Health Service has conducted around 200,000 tests so far and has also scaled up the testing capacity from 5,000 to 10,000 tests per day in the U.K. According to the same source, the National Health Service is planning to increase the capacity to nearly 25,000 swab tests per day by the end of April in the U.K. Hence, the increasing demand for COVID-19 detection is expected to boost the market growth during the forecast period.

Market Dynamics

The increasing adoption of inorganic growth strategies such as partnerships and collaborations by key players to increase the production of COVID-19 tests is expected to propel the market growth during the forecast period. For instance, on April 14, 2020, Co-Diagnostics, Inc., a molecular diagnostics company, collaborated with Promega Corporation, a provider of molecular diagnostic components, to amplify the production of Logix Smart COVID-19 tests. This collaboration will allow Co-Diagnostics, Inc. to meet the demand for COVID-19 tests and strengthen its presence in the U.S.

Similarly, on April 29, 2020, Centene Corporation collaborated with Quest Diagnostics, provider of diagnostic information services to increase availability of real-time reverse transcription polymerase chain reaction (rRT-PCR) COVID-19 testing in the U.S. Through this collaboration, Centene will distribute around 25,000 Quest COVID-19 test kits every week to Federally Qualified Health Centers (FQHCs) in ten states or districts across the U.S.

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global COVID-19 detection kits market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study are Co-Diagnostics, Inc F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific, Abbott Laboratories, BGI, Cepheid Inc, BioFire Diagnostics, GenMark Diagnostics, Qiagen, Quidel Corporation, Randox Laboratories Ltd., SD Biosensor, INC., Shenzhen Bioeasy Biotechnology Co., Ltd., and Seegene Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, Specimen Type up-gradation, market expansion, and marketing tactics
  • The global COVID-19 detection kits market report caters to various stakeholders in this industry including investors, suppliers, drug manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global COVID-19 detection kits market

Detailed Segmentation:

  • Global COVID-19 detection kits Market, By Product Type (Revenue, USD Bn, 2021 - 2033)
  • RT-PCR Assay Kits
  • Immunoassay Test Strips/Cassettes
  • Global COVID-19 detection kits Market, By Specimen Type (Revenue, USD Bn, 2021 - 2033)
  • Nasopharyngeal swab
  • Oropharyngeal swab
  • Nasal swab
  • Sputum
  • Others
  • Global COVID-19 detection kits Market, By End User (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Diagnostic centers
  • Others
  • Global COVID-19 detection kits Market, By Region (Revenue, USD Bn, 2021 - 2033)
  • North America
    • By Product Type
      • RT-PCR Assay Kits
      • Immunoassay Test Strips/Cassettes
    • By Specimen Type:
      • Nasopharyngeal swab
      • Oropharyngeal swab
      • Nasal swab
      • Sputum
      • Others
    • By End User:
      • Hospitals
      • Diagnostic centers
      • Others
    • By Country:
      • U.S.
      • Canada
  • Latin America
    • By Product Type
      • RT-PCR Assay Kits
      • Immunoassay Test Strips/Cassettes
    • By Specimen Type:
      • Nasopharyngeal swab
      • Oropharyngeal swab
      • Nasal swab
      • Sputum
      • Others
    • By End User:
      • Hospitals
      • Diagnostic centers
      • Others
    • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Product Type
      • RT-PCR Assay Kits
      • Immunoassay Test Strips/Cassettes
    • By Specimen Type:
      • Nasopharyngeal swab
      • Oropharyngeal swab
      • Nasal swab
      • Sputum
      • Others
    • By End User:
      • Hospitals
      • Diagnostic centers
      • Others
    • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Product Type
      • RT-PCR Assay Kits
      • Immunoassay Test Strips/Cassettes
    • By Specimen Type:
      • Nasopharyngeal swab
      • Oropharyngeal swab
      • Nasal swab
      • Sputum
      • Others
    • By End User:
      • Hospitals
      • Diagnostic centers
      • Others
    • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Product Type
      • RT-PCR Assay Kits
      • Immunoassay Test Strips/Cassettes
    • By Specimen Type:
      • Nasopharyngeal swab
      • Oropharyngeal swab
      • Nasal swab
      • Sputum
      • Others
    • By End User:
      • Hospitals
      • Diagnostic centers
      • Others
    • By Country:
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Product Type
      • RT-PCR Assay Kits
      • Immunoassay Test Strips/Cassettes
    • By Specimen Type:
      • Nasopharyngeal swab
      • Oropharyngeal swab
      • Nasal swab
      • Sputum
      • Others
    • By End User:
      • Hospitals
      • Diagnostic centers
      • Others
    • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
  • Co-Diagnostics, Inc*
    • Company Overview
    • Material Portfolio
    • Financial Performance
    • Key Highlights
    • Market Strategies
  • Hoffmann-La Roche AG
  • Siemens Healthineers AG
  • Thermo Fisher Scientific
  • Abbott Laboratories
  • BGI
  • Cepheid Inc
  • BioFire Diagnostics
  • GenMark Diagnostics
  • Qiagen
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • SD Biosensor, INC.
  • Shenzhen Bioeasy Biotechnology Co., Ltd.
  • Seegene Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI3839

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Specimen Type
    • Market Snippet, By End User
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Test Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. RT-PCR Assay Kits

  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Segment Trends

5. Immunoassay Test Strips/Cassettes

  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Segment Trends

6. Nasopharyngeal swab

  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Segment Trends

7. Oropharyngeal swab

  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Segment Trends

8. Nasal swab

  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Segment Trends

9. Sputum

  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Segment Trends

10. Others

  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Segment Trends

11. Hospitals

  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)

12. Diagnostic centers

  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)

13. Others

  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)

14. North America

  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021-2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Specimen Type, 2021-2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
    • U.S.
    • Canada

15. Europe

  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021-2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Specimen Type, 2021-2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe

16. Asia Pacific

  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021-2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Specimen Type, 2021-2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific

17. Latin America

  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021-2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Specimen Type, 2021-2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America

18. Middle East

  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021-2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Specimen Type, 2021-2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East

19. Africa

  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021-2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Specimen Type, 2021-2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2021-2033, (US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

20. Competitive Landscape

  • Company Profiles
    • Co-Diagnostics, Inc.*
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • F. Hoffmann-La Roche AG
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Siemens Healthineers AG
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Thermo Fisher Scientific
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Abbott Laboratories
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • BGI
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Cepheid Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • BioFire Diagnostics
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • GenMark Diagnostics
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Qiagen
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Quidel Corporation
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Randox Laboratories Ltd.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • SD Biosensor, INC.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Shenzhen Bioeasy Biotechnology Co., Ltd.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Seegene Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • JOYSBIO Biotechnology
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Cipla Limited
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Bione
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Virax Biolabs Group Limited
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • SD BioSensor, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • NanoSpot.ai
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • J. Mitra & Co. Pvt. Ltd.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Genes2Me
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Ubio Biotechnology Systems Pvt Ltd
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Bharat Biotech
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Gennova Biopharmaceuticals
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • QRX Pharma
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Angstrom Biotech Pvt. Ltd.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Detect, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies

21. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!